According to an official statement on Friday, India has granted homegrown drugmaker Biological E permission to begin midtage studies of its COVID-19 vaccine in children and adolescents.
The Drugs Controller General of India (DCGI) gave the approval to the Hyderabad-based pharmaceutical company on Sept. 1, the statement said.
Arunachal Pradesh currently has 4,266 active cases, while 41,385 people have recovered from the disease thus far, including 360 in the last 24 hours.
Zydus Cadila gets USFDA nod for arthritis drug
Drug firm Zydus Cadila on Monday said it has received final approval from the US
Union health minister Mansukh Mandaviya on Thursday said the government has launched an inquiry into a report claiming that counterfeit versions of Covishield, India’s primary anti-COVID-19 vaccine, had been seized.
“It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The
Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator seeking emergency use authorisation for its COVID-19 vaccine ZyCoV-D next week, official sources said on Friday.
If approved, it will be the world’s first DNA vaccine against coronavirus and the fourth to